NCT01816841

Brief Summary

This clinical trial studies direct visual fluorescence in finding oral cancer in high-risk patients and patients undergoing routine dental care. Diagnostic procedures, such as direct visual fluorescence, may help find and diagnose oral cancer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
68

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2008

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 11, 2008

Completed
4.4 years until next milestone

First Submitted

Initial submission to the registry

March 20, 2013

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 22, 2013

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 3, 2016

Completed
3.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 28, 2019

Completed
Last Updated

January 30, 2020

Status Verified

January 1, 2020

Enrollment Period

7.9 years

First QC Date

March 20, 2013

Last Update Submit

January 29, 2020

Conditions

Keywords

Direct Visual FluorescenseOral Examinationoral cancer

Outcome Measures

Primary Outcomes (2)

  • Sensitivity and specificity of DVFE compared to visual inspection by conventional oral examination alone

    Will be evaluated by calculating sensitivity and specificity and their corresponding exact 95% confidence intervals. Association between the two techniques will be assessed using the simple kappa statistic.

    At the time of examination

  • Differences between lesional margins identified by COE and DVFE

    Will be evaluated using the dependent t-test. In the event that the parametric requirements of this test are not met, the Wilcoxon, matched-pairs, signed-ranks test will be used.

    At the time of examination

Study Arms (2)

Diagnostic (COE and DVFE)- Arm I

EXPERIMENTAL

Arm I - Patients undergo COE followed by DVFE. Patients with tissue abnormalities found by COE or DVFE undergo biopsy within 2 weeks.

Procedure: fluorescence imagingProcedure: biopsyProcedure: examination

Arm II - Comparison of surgical margins using COE vs. DVFE

EXPERIMENTAL

Comparison of surgical margins using COE vs. DVFE

Procedure: fluorescence imagingProcedure: biopsyProcedure: examinationProcedure: Comparison of surgical margins by COE vs. DVFE

Interventions

Undergo DVFE

Arm II - Comparison of surgical margins using COE vs. DVFEDiagnostic (COE and DVFE)- Arm I
biopsyPROCEDURE

Undergo scalpel biopsy

Also known as: biopsies
Arm II - Comparison of surgical margins using COE vs. DVFEDiagnostic (COE and DVFE)- Arm I
examinationPROCEDURE

Undergo COE

Also known as: Exam, Medical Assessment, Medical Exam, Medical Examination, Medical Inspection
Arm II - Comparison of surgical margins using COE vs. DVFEDiagnostic (COE and DVFE)- Arm I

Surgical margin determination using DVFE

Arm II - Comparison of surgical margins using COE vs. DVFE

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • HIGH-RISK POPULATION:
  • consecutive consenting patients presenting to The Ohio State University James Cancer Hospital Otolaryngology Department with a suspicious oral lesion or prior biopsy-confirmed epithelial dysplasia (mild, moderate, severe), carcinoma in situ (CIS), or squamous cell carcinoma (SCC) will be recruited; adult patients presenting for initial evaluation for treatment planning and/or presenting for follow-up appointments monitoring for recurrence will be eligible to participate
  • GENERAL POPULATION:
  • consecutive consenting patients presenting to The Ohio State University College of Dentistry for routing dental care will be recruited; adult patients presenting to the screening clinic for initial oral evaluation will be eligible to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center

Columbus, Ohio, 43210, United States

Location

Related Links

MeSH Terms

Conditions

Lymphoid Interstitial PneumoniaSquamous Cell Carcinoma of Head and NeckMouth NeoplasmsTongue Neoplasms

Interventions

Optical ImagingBiopsyRestraint, PhysicalIndependent Medical Evaluation

Condition Hierarchy (Ancestors)

Carcinoma, Squamous CellCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsHead and Neck NeoplasmsNeoplasms by SiteMouth DiseasesStomatognathic DiseasesTongue Diseases

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisInvestigative TechniquesCytodiagnosisCytological TechniquesClinical Laboratory TechniquesSpecimen HandlingDiagnostic Techniques, SurgicalSurgical Procedures, OperativeBehavior ControlTherapeuticsImmobilizationHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and Evaluation

Study Officials

  • Kristin McNamara, DDS, MS

    Ohio State University Comprehensive Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 20, 2013

First Posted

March 22, 2013

Study Start

November 11, 2008

Primary Completion

October 3, 2016

Study Completion

December 28, 2019

Last Updated

January 30, 2020

Record last verified: 2020-01

Data Sharing

IPD Sharing
Will not share

Locations